case studies

Real Clients. Real Results.

Case Study > Category
Case Study > Solution

16 Mar 2026

28 May 2024

Cell and Gene Pharmaceuticals and Biotech Market Access

CMMI Engagement on CGT Model

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

28 May 2024

20 Dec 2023

20 Dec 2023

20 Dec 2023

15 Dec 2023

29 Nov 2022

Market Access

Product Positioning for a Novel Cancer Therapy

ADVI assisted a client in Phase II development of a novel cancer therapy in preparing for launch, holding discussions with potential commercial payers and CMS.

19 Sep 2022

Market Access

Launch Roadmap for a Novel Vaccine

A global pharmaceutical client asked ADVI to support the launch of a novel vaccine with multiple intended uses.

19 Sep 2022

Market Access

Value Based Payment for Gene Therapy

ADVI helped develop an outcomes-based payment approach for a one-time, curative gene therapy manufacturer to use in reimbursement discussions with state Medicaid programs and commercial payers.

19 Sep 2022

Market Access

Metastatic Melanoma Cell Therapy Launch

Created a comprehensive launch strategy and payer plan for a novel cell therapy to treat metastatic melanoma, including high-level timelines for internal launch planning, payer engagement, strategic release of data and communication approaches, and a detailed database containing information on top influencers and payer organizations.

19 Sep 2022

Reach out

Own your edge

We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.